Therapeutic options in BK virus-associated interstitial nephritis

Kidney International

Volumn 70, Issue 2, 2006, Pages 399-402

  Crew, R J ^a   Markowitz, G ^a   Radhakrishnan, J ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; AZATHIOPRINE; CALCIUM; CIDOFOVIR; COTRIMOXAZOLE; DACLIZUMAB; GANCICLOVIR; IRON; LEFLUNOMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; VITAMIN D;

ADULT; ANAMNESIS; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BK VIRUS; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DYSURIA; FEMALE; FEVER; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; URINARY TRACT INFECTION;

ADULT; ANTIVIRAL AGENTS; BIOPSY; BK VIRUS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; NEPHRITIS, INTERSTITIAL; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; TUMOR VIRUS INFECTIONS;

EID: 33746148528     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001540     Document Type: Article

References (19)

1. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1: 1253-1257.
2. Menahem SA, McDougall KM, Thomson NM, Dowling JP. Native kidney BK nephropathy post cardiac transplantation. Transplantation 2005; 79: 259-260.
3. Nebuloni M, Tosoni A, Boldorini R et al. BK virus renal infection in a patient with the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1999; 123: 807-811.
4. Hirsch HH, Brennan DC, Drachenberg CB et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277-1286.
5. Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488-496.
6. Brennan DC, Agha I, Bohl DL et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582-594.
7. Coleman DV, Mackenzie EF, Gardner SD et al. Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients. J Clin Pathol 1978; 31: 338-347.
8. Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103-109.
9. Ramos E, Drachenberg CB, Portocarrero M et al. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland renal transplant program. In: Terasaki P, Cecka M (eds). Clinical Transplants. Ucla Tissue Typing Laboratory: MD, 2002, pp 143-153.
10. Wali RK, Drachenberg C, Hirsch HH et al. BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression. Transplantation 2004; 78: 1069-1073.
11. Lipshutz GS, Flechner SM, Govani MV, Vincenti F. BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen. Am J Transplant 2004; 4: 2132-2134.
12. Comoli P, Basso S, Azzi A et al. Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. J Am Soc Nephrol 2003; 14: 3197-3204.
13. Held TK, Biel SS, Nitsche A et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 2000; 26: 347-350.
14. Bjorang O, Tveitan H, Midtvedt K et al. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient. Nephrol Dial Transplant 2002; 17: 2023-2025.
15. Vats A, Shapiro R, Singh RP et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75: 105-112.
16. Knight DA, Hejmanowski AQ, Dierksheide JE et al. Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide. Transplantation 2001; 71: 170-174.
17. Williams JW, Javaid B, Kadambi PV et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005; 352: 1157-1158.
18. Nickeleit V, Klimkait T, Binet IF et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309-1315.
19. Ramos E, Vincenti F, Lu WX et al. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation 2004; 77: 131-133.